Specific polymorphisms of cytokine genes are associated with different risks to develop single-system or multi-system childhood Langerhans cell histiocytosis

Authors


Dr Maurizio Aricò, U.O. Onco-Ematologia Pediatrica, Ospedale dei Bambini ‘G. Di Cristina’, Via Benedettini 1, 90134 Palermo, Italy.
E-mail: arico@ospedalecivicopa.org

Summary

Cytokines and chemokines determine mobilisation of Langerhans cells and their dysregulation is implicated in the pathogenesis of Langerhans cell histiocytosis (LCH). Twenty point mutations of 12 different cytokine genes were studied in 41 Italian children, 15 with single-system (SS) and 26 with multi-system disease. The allele and genotype distributions of interleukin-4 (IL-4) and interferon-γ (IFNγ) were significantly different in patients vs. 140 controls (P = 0.007, and P = 0.018). Older children with single-system disease shared the ‘anti-inflammatory profile’ determined by the intermediate producer genotype IFNγ +874A/T (P = 0.029) and the high-producer genotypes IL-4 –590C/T and T/T (P = 0.029). Our findings suggest that specific cytokine gene variants affect susceptibility to LCH and its clinical heterogeneity.

Ancillary